Staff

GARIS PANDUAN PENGENDALIAN MEDICINES ACCESS SCHEME (MASc) DI FASILITI KKM (EDISI KEDUA 2024)

MOH facilities often receive Medicines Access Schemes (MASc) or medicines schemes offered by pharmaceutical companies to improve patient access to new medicines with high financial impact.

English

Medication Error (ME) Reporting

The Medication Error Reporting System (MERS) is a national-level reporting system introduced by the Pharmaceutical Services Programme, Ministry of Health Malaysia, since 2009.

English

Happy Eid Mubarak 1440

Location/place: 
Program Perkhidmatan Farmasi
Date: 
Monday, 3 June 2019 to Sunday, 16 June 2019

KIKF 2019 finalist

Please check out the finalists of the Pharmaceutical Innovation & Creativity Convention 2019 at http://bit.ly/finalistKIKF19.

Congratulations and good luck to those who are successfully selected to the final stage!

Nephrology MTAC Protocol (Second Edition 2019)

This protocol encompasses the modules for Chronic Kidney Disease MTAC (CKD-MTAC), Dialysis MTAC and Renal Transplant MTAC (RTX-MTAC). The benefits of MTAC services have shown to improve the quality, safety and cost effectiveness of patient care. Today, a total of 40 major hospitals are providing at least one Nephrology MTAC services.

English

Konvensyen Inovasi dan Kreativiti Farmasi 2019

For more information please visit https://kikf.pharmacy.gov.my

Location/place: 
Johor Bahru
Date: 
Monday, 5 August 2019 to Wednesday, 7 August 2019

National Oncology Pharmacy Conference (NOPC2.0)

Jabatan Farmasi, Institut Kanser Negara, akan menganjurkan Persidangan Farmasi Onkologi (NOPC2.0) pada 9-11 April 2019. Tema persidangan ini ialah 'An ounce of action is worth a pound of cure'. Borang pendaftaran dan maklumat yang berkaitan boleh diperoleh melalui pautan: https://goo.gl/forms/8eIQVZEpZky5RC722

Location/place: 
Auditorium, Institut Kanser Negara, Wilayah Persekutuan Putrajaya
Date: 
Tuesday, 9 April 2019 to Thursday, 11 April 2019

Medicine Prices Monitoring 2017

Medicine Prices Monitoring surveys has been conducted by the MOH since 2006 and provides comprehensive information on availability, prices and affordability of medicines in Malaysia. The study methodology was adapted from the guidelines by the World Health Organization (WHO) and Health Action International (HAI) to improve global monitoring of medicine prices.

English

Pages